Crossmark

BDNF Val66Met polymorphism is associated with negative symptoms in early-onset schizophrenia spectrum and other psychotic disorders

Crossref DOI link: https://doi.org/10.1016/j.ejpsy.2021.04.002

Published Print: 2022-01

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Karacetin, G.

Bayoglu, B. http://orcid.org/0000-0001-6568-6398
Eseroglu Soylemez, T. http://orcid.org/0000-0002-6921-4985
Topal, M.

Bulanik Koc, E. http://orcid.org/0000-0003-0505-4932
Tekden, M. http://orcid.org/0000-0002-3085-1725
Ermis, C. http://orcid.org/0000-0002-8412-8049
Demir, T.

Elagoz Yuksel, M.

Ercan, E.S.

Erkiran, M.

Aksoyer Sezgin, S.B. http://orcid.org/0000-0002-8338-9546
Cengiz, M.
Funding

Funding for this research was provided by:

Istanbul University

Istanbul Üniversitesi-Cerrahpasa (42496, 54033)
License Information

Text and Data Mining valid from 2022-01-01
More Information

This article is maintained by: Elsevier

Article Title: BDNF Val66Met polymorphism is associated with negative symptoms in early-onset schizophrenia spectrum and other psychotic disorders

Journal Title: The European Journal of Psychiatry

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.ejpsy.2021.04.002

Content Type: article

Copyright: © 2021 Asociación Universitaria de Zaragoza para el Progreso de la Psiquiatría y la Salud Mental. Published by Elsevier España, S.L.U. All rights reserved.